CAS 449811-92-1

Fórmula: C19H18F2N4O3

InChI: InChI=1S/C19H18F2N4O3/c1-25-17-11(10-22-19(24-17)23-13-4-6-27-7-5-13)8-16(18(25)26)28-15-3-2-12(20)9-14(15)21/h2-3,8-10,13H,4-7H2,1H3,(H,22,23,24)

Chave InChI: KKKRKRMVJRHDMG-UHFFFAOYSA-N

SMILES: CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC4CCOCC4

R1487

CAS: 449811-92-1

R1487

Fórmula: C₁₉H₁₈F₂N₄O₃

Pureza: ≥95%

Peso molecular: 388.37

Ref: 54-BUP00872

6-(2,4-difluorophenoxy)-8-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one

CAS: 449811-92-1

Fórmula: C₁₉H₁₈F₂N₄O₃

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 388.3680

Ref: IN-DA00DLSK

R1487

CAS: 449811-92-1

R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.

Fórmula: C₁₉H₁₈F₂N₄O₃

Pureza: 99.77%

Cor e Forma: Solid

Peso molecular: 388.368

Ref: TM-T7667

6-(2,4-Difluorophenoxy)-8-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one

CAS: 449811-92-1

6-(2,4-Difluorophenoxy)-8-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one is a synthetic organic compound, specifically a pyrido[2,3-d]pyrimidine derivative. It is designed through organic synthesis processes that involve strategic modifications to achieve specific chemical characteristics. The compound acts primarily as an inhibitor within various biochemical pathways, targeting specific molecular interactions involved in pathological conditions.

Fórmula: C₁₉H₁₈F₂N₄O₃

Pureza: Min. 95%

Peso molecular: 388.4 g/mol

Ref: 3D-ZSA81192